Masivo Highlights Wide Historic High-Grade Results from Cerro Colorado and Announces Equity RaiseJune 27, 2025 11:30 AM EDT | Source: Masivo Silver Corp.Vancouver, British Columbia--(Newsfile Corp. - June 27, 2025) - Masivo Silver Corp. (TSXV: MASS) (OTC Pink: GNYPF) ("Masivo" or the "Company") is pleased to report encouraging historic results from the two known drill holes completed at the drill target for Cerro Colorado Gold-Silver Project in Sonora, Mexico, as the Company advances final due ...

Investors might want to bet on 908 Devices Inc. (MASS) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Individual inves ...

Strategic Transformation Realized MARCH 5th 2025 designed for 'point-of-need' use in vital health and safety contexts Forward looking statements / Non-GAAP financial measures This presentation and the accompanying oral presentation (this "presentation") contain forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements may relate to, but are not limited to, expectations ...

Lastly, this presentation incudes certain financial measures not prepared in accordance with generally accepted accounting principles ("GAAP"), including adjusted gross profit, adjusted gross margin percentage and adjusted EBITDA. These non-GAAP financial measures should be considered as a supplement to and not a substitute for GAAP financial measures. Reconciliations to the most directly comparable GAAP financial measures can be found in this presentation. 2 Analysis at the speed of life MAY 2025 Forward l ...

Summary of 908 Devices (MASS) FY Conference Call - June 04, 2025 Company Overview - **Company**: 908 Devices - **Industry**: Handheld chemical detection technology for public health, safety, and defense Key Themes and Core Points 1. **Strategic Transformation**: The company has completed a significant transformation, exiting the desktop business and focusing solely on handheld chemical detection, which is expected to enhance operational alignment and financial performance [5][6][11] 2. **Financial Performance**: The company is on track to achieve adjusted EBITDA breakeven by Q4 2025 and anticipates full-year cash flow positivity by 2026 [9][40][42] 3. **Market Opportunity**: The total addressable market (TAM) for handheld devices is projected to reach $2.5 billion by 2027, with the handheld revenue growth outpacing that of the desktop segment [12][40] 4. **Product Portfolio Expansion**: The product lineup has expanded from one to four handheld devices, with plans to increase to six by 2026, enhancing the company's ability to address critical health and safety applications [39][41][43] 5. **Revenue Growth**: Q1 2025 revenue reached $11.8 million, a 59% year-over-year increase, driven by an 86% increase in handheld product and service revenue [47][48] 6. **Recurring Revenue**: Recurring revenue grew by 54% year-over-year, indicating strong demand for services and consumables [48] 7. **Cash Position**: The company ended Q1 2025 with approximately $124 million in cash, bolstered by a $70 million inflow from the divestiture of the desktop business [50] Industry Dynamics 1. **Opioid Crisis**: The company is positioned to address the escalating opioid crisis, with increasing demand for advanced detection technologies to combat synthetic drugs [15][16][18] 2. **Global Security Concerns**: Heightened global security needs are driving demand for modern detection tools, with NATO allies projected to increase defense spending significantly [20][22][23] 3. **Public Funding Trends**: There is a favorable funding environment for public safety technologies, with increased investments across various sectors including law enforcement and military [19][23] Additional Insights 1. **Sales Cycle Variability**: The sales cycle varies significantly across different channels, with state and local sales often turning around quickly, while federal military sales can take years [55][56] 2. **Competitive Positioning**: The company emphasizes its comprehensive service approach and modern technology to compete against legacy products in the market [60] 3. **Future Growth Catalysts**: Key growth drivers include the modernization of outdated FTIR units, the launch of next-generation handheld devices, and the full-rate production of the U.S. DoD AvCAD program, which could add over $10 million in annual revenue potential [32][36][42] Conclusion 908 Devices is undergoing a transformative phase, focusing on handheld chemical detection with a robust product portfolio and a favorable market environment. The company is positioned for sustainable growth, backed by strong financials and macro trends in public health and safety.

Core Insights - A deal with the Romanian Customs Authority has significantly boosted the stock price of 908 Devices, which rose over 18% [1][8] Group 1: Deal Announcement - 908 Devices announced the deployment of 27 MX908 devices by the Romanian Customs Authority [2] - The MX908 devices are handheld machines capable of rapid chemical analysis, identifying various substances in seconds [4] - The deal was facilitated through a European Union program aimed at enhancing border control capabilities for member nations [5] Group 2: Company Impact - The CEO of 908 Devices highlighted the proactive measures taken by the Romanian Customs Authority to enhance safety and security at the border [6] - Although financial details of the deal were not disclosed, it is expected to generate revenue and improve the company's reputation [7]

908 Devices Inc. (MASS) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Since a changing ear ...

908 Devices (MASS) Q1 2025 Earnings Call May 13, 2025 08:30 AM ET Company Participants Kelly Gura - Vice PresidentKevin Knopp - Co-Founder, CEO & DirectorJoseph Griffith - CFODaniel Arias - Managing DirectorPuneet Souda - Senior MD Conference Call Participants Matt Larew - Research Analyst - HealthcareBrendan Smith - Director & Senior Analyst Operator Hello, and welcome, everyone, to the nine zero eight Devices First Quarter twenty twenty five Financial Results Conference Call. My name is Becky, and I'll be ...

908 Devices (MASS) Q1 2025 Earnings Call May 13, 2025 08:30 AM ET Speaker0 Hello, and welcome, everyone, to the nine zero eight Devices First Quarter twenty twenty five Financial Results Conference Call. My name is Becky, and I'll be your operator today. I will now hand over to your host, Kelly Gura, Investor Relations, to begin. Please go ahead. Speaker1 Thank you. This morning, nine zero eight Devices released financial results for the first quarter ended 03/31/2025. If you've not received this news relea ...

908 Devices Inc. (MASS) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.33 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 18.52%. A quarter ago, it was expected that this company would post a loss of $0.35 per share when it actually produced a loss of $0.32, delivering a surprise of 8.57%.Over the last four quarters, the company has surpasse ...